Screener
ADMA Biologics ADMA EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
| Line item | Three Months ended June 30, 2026 | Three Months ended June 30, 2025 | Six Months ended June 30, 2026 | Six Months ended June 30, 2025 |
|---|---|---|---|---|
| INCOME BEFORE INCOME TAXES | 50,237 | 40,097 | 107,365 | 73,546 |
| Provision for income taxes | 12,415 | 5,878 | 24,215 | 12,424 |
| NET INCOME | $$37,822 | $34,219 | $83,150 | 61,122 |
| BASIC EARNINGS PER COMMON SHARE | $$0.17 | $0.14 | $0.36 | 0.26 |
| DILUTED EARNINGS PER COMMON SHARE | $$0.16 | $0.14 | $0.35 | 0.25 |
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: | ||||
| Basic | 228,232,503 | 241,490,715 | 232,136,480 | 238,309,156 |
| Diluted | 230,337,048 | 248,608,460 | 235,240,375 | 245,750,155 |
Item 1. Financial Statements.
FAQ
- What is ADMA Biologics's EPS (diluted)?
- ADMA Biologics (ADMA) reported EPS (diluted) of $0.16 in Q2 2026.
- How has ADMA Biologics's EPS (diluted) changed year-over-year?
- ADMA Biologics's EPS (diluted) increased by 14.3% year-over-year, from $0.14 to $0.16.
- What is the long-term trend for ADMA Biologics's EPS (diluted)?
- Over 4 years (2021 to 2025), ADMA Biologics's EPS (diluted) has grown at a 4.1% compound annual growth rate (CAGR), from -$0.51 to $0.60.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about ADMA Biologics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude